Advertisement

Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 940–941 | Cite as

ASO Author Reflections: Rationale for Organ Resection for Retroperitoneal Sarcomas

  • Mark Fairweather
  • Chandrajit P. Raut
ASO Author Reflections
  • 48 Downloads

Notes

Disclosure

The authors have no conflicts of interest to disclose.

References

  1. 1.
    Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2009;27:24–30.CrossRefGoogle Scholar
  2. 2.
    Bonvalot S, Miceli R, Berselli M, et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control. Ann Surg Oncol. 2010;17:1507–14.CrossRefGoogle Scholar
  3. 3.
    Gronchi A, Miceli R, Shurell E, et al. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. J Clin Oncol. 2013;31:1649–55.CrossRefGoogle Scholar
  4. 4.
    Fairweather M, Wang J, Jo VY, et al. Surgical management of primary retroperitoneal sarcomas: rationale for selective organ resection. Ann Surg Oncol. 2018;25:98–106.CrossRefGoogle Scholar
  5. 5.
    EORTC. A phase III randomized study of preoperative radiotherapy plus surgery versus surgery alone for patients with retroperitoneal sarcomas-STRASS. http://www.eortc.be/clinicaltrials/Details.asp?Protocol=6209&7=.

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Department of SurgeryBrigham and Women’s HospitalBostonUSA
  2. 2.Harvard Medical SchoolBostonUSA
  3. 3.Center for Sarcoma and Bone OncologyDana-Farber/Brigham and Women’s Cancer CenterBostonUSA

Personalised recommendations